Article Text


SAT0044 Class ii mhc molecules in patients with sporadic ankylosing spondylitis in the southern european population
  1. VC Perez-Guijo,
  2. E Muñoz-Gomariz,
  3. A Escudero,
  4. M Romero,
  5. MA Aguirre,
  6. J Gonzalez,
  7. FG Martinez,
  8. MC Muñoz-Villanueva,
  9. C Castro,
  10. R Solana,
  11. J Peña,
  12. E Collantes
  1. Rheumatology Service, Hospital Universitario Reina Sofia, Cordoba, Spain


Background To evaluate the relationship between the presence of HLA-DRB1 genes and predisposition to AS in a demographically well-defined population.

Objectives 113 individuals with sporadic (non-familial) Ankylosing Spondylitis (AS) from six different cities and 747 bone marrow donors (BMD) as control group.

Methods All individuals were typed for HLA-B27 by either flow cytometry with monoclonal antibodies or PCR-SSP, as well as for HLA-DRB using the Dynal ELITM SSO HLA-DRB Test (Dynal AS, Oslo, Norway). The Inno-Lipa DRB key and DRB Decoder (Innogenetics NV Zwijndrecht, Belgium), which is based on PCR-SSO technology, was used for high-resolution HLA -DRB typing.

Results Table 1 shows the results.

Abstract SAT0044 Table 1

Conclusion The incidence of the DRB1*01 antigen in the studied population is significantly higher in B27(+) healthy individuals (BMD) than in B27(+) AS patients. Also the incidence of this antigen is significantly higher in B27(-) AS patients than B27(-) healthy individuals. This could implicate that in the absence of B27, the DRB1*01 antigen could take part in the development of the disease.

Statistics from

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.